OxySure Earnings Presentation - 1Q2014 v2.pdf May. 2014 | Page 11

Consolidated Balance Sheets, cont. LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities Accounts payable and accrued expenses Related party payable Deferred revenue Capital leases - current Notes payable - current, net of discount Convertible notes payable, net of discount Total current liabilities Long-term liabilities Capital leases Notes payable, net of discount Total long-term liabilities $ 352,021 29,501 308,553 47,103 252,643 989,821 $ 147,719 118,627 2,976 309,129 44,000 229,903 852,354 554 76,072 76,626 554 76,072 76,626 1,066,448 928,980 693,750 Series A convertible preferred shares issued and outstanding as of March 31, 2014 and 743,750 shares issued and outstanding as of December 31, 2013. 346 371 750 Series B convertible preferred shares issued and outstanding as of March 31, 2014 and 750 shares issued and outstanding as of December 31, 2013. - - 10,391 16,669,538 (15,663,968) 10,343 16,700,307 (15,2